Metabolic Care Without Injections: Do I Have to Inject Anything?

You have a folder of lab printouts, a supplement routine you chose with care, and a quote from a concierge practice for $20,000 a year. You have no wish to inject yourself with anything, and nearly every advertisement for metabolic medicine opens with a pen. So the question is fair: does serious metabolic care without injections exist, or is the needle the price of entry?

This piece answers it by following one patient through her first three months with GoodLife Health. She is a composite, written to illustrate the sequence, and not a real person; her details exist only to make each step concrete. Along the way we say what we would check, why we would check it, what it costs and where the membership stops. If you would rather start with whether we can take you at all, the eligibility check is just below.

A full lab folder, a concierge quote and one firm line

We will call her Maren. She is in the years around menopause, and lately her sleep has thinned, her weight has settled around her middle and her afternoons have lost their energy. She has not ignored any of it. She pays for a longevity lab subscription, she has had a hormone consultation, and she takes a short list of supplements she chose after a lot of reading.

She has plenty of data and no one reading it as one picture. One report called her cholesterol fine; another flagged a particle count as worth watching. Her fasting glucose sits inside the normal range, which reassures her less than it used to. The hormone consultation ended in an offer of pellets, which she declined, because having something implanted felt too close to the thing she was trying to avoid.

She has weighed two very different ways forward. The first is the concierge practice, where she has been promised a physician with time and a phone that gets answered, for $20,000 a year. The second is the apps at around $99 a month that lead with a compounded GLP-1. She set the apps aside quickly. A friend of hers is on a weekly injection, and Maren has watched the routine closely enough to know she does not want it. She also distrusts any service whose business seems to be the shipment, because a service paid by the shipment has every reason to find that she needs one.

So her line is firm: no injections. Underneath it sits the worry she actually typed into a search bar. If she signs up for anything with the word metabolic in its name, will she be steered toward a pen anyway, politely and repeatedly, until she gives in?

The worry is reasonable, because care is usually split across several doors. A weight-loss service manages the drug, a hormone clinic manages the hormones, and an annual primary care visit glances at the cholesterol. Each door treats a symptom, and none of them is paid to read the whole picture. Maren's spending has bought her more information than most people ever see, and it has not bought her a plan.

The needle question belongs after the diagnosis

Two things are going on in Maren's situation, and neither is really about needles.

The first is the business model behind most metabolic medicine. Many telehealth platforms earn more when a patient is prescribed more, through a margin on the molecule or an upcharge as the dose rises. In that model, steering a patient toward an injection is good business, whatever the patient said at intake. GoodLife Health is built the other way round. The membership fee is the same whatever medication is indicated and whatever the dose, with no molecule upcharge and no dose upcharge. Medication is prescribed, when clinically indicated, to the pharmacy the patient chooses, at that pharmacy's own price, and GoodLife Health sets nothing, sees nothing and takes nothing on it.

The second is the order of operations. The model is labs first: diagnosis, then treatment, then the long haul. That order matters for Maren because her symptoms have several plausible drivers, and they point toward different treatments. Insulin resistance drives weight gain, visceral fat disrupts hormones, disrupted hormones stall metabolism, and a stalled metabolism feeds vascular inflammation. A thyroid that is quietly underperforming can stall any protocol, and a hormonal transition can be what drives the weight in the first place. Until those threads are separated in her blood, nobody can honestly tell her what her treatment will be, so nobody can honestly tell her whether it will involve an injection. A service that answers that question before it has seen her labs is answering a sales question.

There is one needle we will not pretend away. Labs are drawn from a vein, and the membership includes four cardiometabolic panels a year. If even a blood draw is out of the question, this model cannot work, because the labs are what everything else is read against.

Beyond the blood draw, the picture is narrower than the advertisements suggest. Weight is one axis of the system, and a GLP-1 is one possible tool on that axis. When a GLP-1 is indicated, the pens are not the only branded option. And some of what hormone clinics commonly offer, pellets among them, we do not offer at all.

Maren's distrust of the $99 apps deserves a factual answer. We prescribe branded, FDA-approved medication only, and never a compounded GLP-1. The FDA has published its concerns about unapproved GLP-1 drugs used for weight loss, the manufacturers have gone to court over compounded copies, and dosing and additive practices have been reported that differ from the approved products. The clinician who prescribes carries the responsibility on their license. Those are the reasons we stay with branded medication, and they are all we would say about it.

Maren's first three months, and what we would check

Before anything: the check, the intake and a clinician's review

Maren starts with the eligibility check, then completes the intake, then checks out. At checkout $598 is charged, which covers her first two months of a membership that is $299 a month, month to month. A clinician then reviews her intake, and not everyone is accepted. If the clinician cannot accept her into care, the $598 is refunded in full; once she is accepted, the first two months are non-refundable. Any medication a pharmacy later bills her follows that pharmacy's own return and refund policy. The membership fee is generally eligible for HSA or FSA pre-tax dollars, which suits someone who already routes health spending through an account. Her line goes into the intake in plain words: no injections.

Month one: the first panel, and why each part is on it

Maren's first panel is broader than an annual physical and more connected than her subscription reports. Here is what we would check, and why.

• Insulin markers and HbA1c. Fasting insulin can rise years before glucose moves, so her normal fasting glucose is real information that does not settle the question of insulin resistance on its own.
• ApoB, Lipoprotein(a) and the full lipid panel. ApoB can stay a problem after the scale improves, which makes weight a poor measure of whether her cardiovascular risk is changing, and one consistent panel replaces the two reports that disagreed.
• hs-CRP. Inflammation is part of how a stalled metabolism reaches the blood vessels, and this marker tracks it.
• A full thyroid panel. A quietly underperforming thyroid can stall any plan built on top of it.
• A full hormone panel. In the years around menopause, the hormonal transition can be what drives the weight in the first place.

Every result is read against optimal ranges rather than population reference ranges, and every result is in Maren's hands. Her old printouts come too, as history. Then she has a video visit with her clinician, who walks her through what the panel shows and what it cannot show.

Month two: a plan that respects the line

What happens next depends on the panel, and with a composite we can describe the branches honestly without pretending to know which one Maren takes.

If the panel points to her thyroid or to the hormonal transition, the clinician may prescribe thyroid medication or hormone therapy where indicated, sent to the pharmacy she chooses. Hormone therapy with us never means pellets, because we perform no in-office procedures. The form of any therapy is something she settles with her clinician, and her preference is part of that conversation.

If the panel shows insulin resistance and the clinician judges a GLP-1 indicated, her line still holds. Through NovoCare, the Wegovy pill is from $149 a month at lower doses, the manufacturer's self-pay price as published in September 2026. At the same source and date, Wegovy pens were $199 a month for the first two fills (an introductory offer for new patients through December 2026) and $349 a month after. She can take the pill and never open a pen, and doses are held at the lowest effective level.

If the panel shows nothing that calls for medication, nothing is prescribed, and the fee is the same.

Whatever the branch, insurance is a separate matter. Whether a plan covers a medication is between Maren, her plan and her pharmacy; prior authorization is the pharmacy's process, and we never claim to run it or promise its outcome. Through the month she uses asynchronous messaging with the care team for the questions that arrive at odd hours: a side effect, a pharmacy question, a result she wants to read again.

Month three: the second panel

At the quarter, Maren's second panel is drawn, and this is where the model earns its keep. Her clinician compares it with the first and asks whether whatever is being treated is actually moving. If her insulin markers, ApoB, thyroid or hormone levels shift, the plan follows them; if they do not, the plan changes. A dose can be held, lowered or stopped, and stopping, when the labs support it, counts as a success.

We will not tell you what Maren's second panel shows, because no one can promise a result and we do not. At the end of her third month she has two complete panels, a clinician who has read both, and a plan built on them. From there the membership continues at $299 a month, month to month, or she cancels.

What it costs, beside the concierge quote

A concierge practice offers things we do not. If a physician in the same room and procedures in an office are what Maren values most, that is what the higher price buys, and we would tell her so. GoodLife Health sits between the $20,000-a-year concierge practice and the $99-a-month compounded app, and says so: clinician-led care from clinicians licensed in all fifty states, delivered by video visits and messaging, with labs at the center. The membership replaces the primary-care relationship and pairs with insurance for catastrophic coverage; it does not replace insurance.

What the membership will not do

It will not promise a result: no guaranteed weight loss, no remission, no cure. It will not promise a prescription, because the clinician decides what is indicated. It does not include continuous glucose monitors, so if Maren's longevity spending includes one, that stays her own choice outside the model. And it will not tell her that any medication will be covered by her insurance.

The honest answer to 'I do not want to inject anything'

You can join GoodLife Health without agreeing to inject anything. Medication is prescribed only when it is clinically indicated, and that decision comes after the labs. If a GLP-1 turns out to be indicated, the Wegovy pill is one of the branded options a clinician can prescribe. If a finding ever had no good answer except an injection, you would be told so plainly, with the reasoning, and the decision to take it would stay yours; the fee would not change either way.

What you cannot avoid is the blood draw, four panels a year, because the labs are the point. For a reader who already pays for labs and hormones and still has no plan, that may be the trade worth looking at: one clinician reading the whole picture every quarter, at $3,588 a year plus whatever your pharmacy charges for anything prescribed.

Who this is not for

If you want a GLP-1 shipped this week for $99 a month, we are the wrong choice; we prescribe branded medication only, after labs, and only when indicated. If you want a physician in a room, procedures in an office or pellets, a concierge or hormone practice is built for that and we are not. If you want a guaranteed result, a guaranteed prescription or a promise that your insurance will cover a medication, no honest service can give you one, and we will not. If you want the membership to replace your health insurance, it cannot; it pairs with it. And if you cannot face a blood draw four times a year, this model will not work for you, because everything we do is read from those panels.

Related Reading

• The True Monthly Cost of GLP-1 Telehealth: An Honest Comparison
• Cardiometabolic Optimization: The Definitive Guide

References

1. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
2. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss